1643 Stock Overview
Modern Chinese Medicine Group Co., Ltd., an investment holding company, produces and sells proprietary Chinese medicines for elderlies and aged-middle in the People's Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Modern Chinese Medicine Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.32 |
| 52 Week High | HK$0.53 |
| 52 Week Low | HK$0.29 |
| Beta | 0.36 |
| 1 Month Change | -14.86% |
| 3 Month Change | -4.55% |
| 1 Year Change | -35.05% |
| 3 Year Change | -65.00% |
| 5 Year Change | n/a |
| Change since IPO | -75.00% |
Recent News & Updates
Lacklustre Performance Is Driving Modern Chinese Medicine Group Co., Ltd.'s (HKG:1643) Low P/E
Mar 25
Recent updates
Lacklustre Performance Is Driving Modern Chinese Medicine Group Co., Ltd.'s (HKG:1643) Low P/E
Mar 25We Think You Should Be Aware Of Some Concerning Factors In Modern Chinese Medicine Group's (HKG:1643) Earnings
Sep 02Calculating The Fair Value Of Modern Chinese Medicine Group Co., Ltd. (HKG:1643)
Jun 07Shareholder Returns
| 1643 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | -1.6% | -3.9% | -0.7% |
| 1Y | -35.1% | -21.9% | -13.4% |
Return vs Industry: 1643 underperformed the Hong Kong Pharmaceuticals industry which returned -21.9% over the past year.
Return vs Market: 1643 underperformed the Hong Kong Market which returned -13.4% over the past year.
Price Volatility
| 1643 volatility | |
|---|---|
| 1643 Average Weekly Movement | 10.9% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 7.5% |
| 10% most volatile stocks in HK Market | 14.9% |
| 10% least volatile stocks in HK Market | 3.8% |
Stable Share Price: 1643 has not had significant price volatility in the past 3 months.
Volatility Over Time: 1643's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 191 | Hongli Zhang | www.cdysjdyy.com |
Modern Chinese Medicine Group Co., Ltd., an investment holding company, produces and sells proprietary Chinese medicines for elderlies and aged-middle in the People's Republic of China. The company offers therapeutics for the qi-deficiency and blood-statis, cardio-cerebrovascular, digestive and gastrointestinal, gynecological, respiratory system, and nervous system conditions. It also provides business support, technical, and consulting services.
Modern Chinese Medicine Group Co., Ltd. Fundamentals Summary
| 1643 fundamental statistics | |
|---|---|
| Market cap | HK$189.00m |
| Earnings (TTM) | HK$52.79m |
| Revenue (TTM) | HK$372.25m |
3.6x
P/E Ratio0.5x
P/S RatioIs 1643 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1643 income statement (TTM) | |
|---|---|
| Revenue | CN¥344.08m |
| Cost of Revenue | CN¥239.90m |
| Gross Profit | CN¥104.18m |
| Other Expenses | CN¥55.38m |
| Earnings | CN¥48.80m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.081 |
| Gross Margin | 30.28% |
| Net Profit Margin | 14.18% |
| Debt/Equity Ratio | 0% |
How did 1643 perform over the long term?
See historical performance and comparison